Logo image of ELES.MI

ELES SEMICONDUCTOR EQUIPMENT (ELES.MI) Stock Fundamental Analysis

BIT:ELES - Euronext Milan - IT0005373417 - Common Stock - Currency: EUR

1.6  +0.07 (+4.23%)

Fundamental Rating

5

ELES gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 53 industry peers in the Semiconductors & Semiconductor Equipment industry. ELES has an average financial health and profitability rating. ELES is not overvalued while it is showing excellent growth. This is an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ELES had positive earnings in the past year.
In the past year ELES had a positive cash flow from operations.
Each year in the past 5 years ELES has been profitable.
Of the past 5 years ELES 4 years had a positive operating cash flow.
ELES.MI Yearly Net Income VS EBIT VS OCF VS FCFELES.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 2M 4M 6M

1.2 Ratios

The Return On Assets of ELES (2.24%) is worse than 79.25% of its industry peers.
ELES has a worse Return On Equity (4.47%) than 73.58% of its industry peers.
ELES has a Return On Invested Capital of 6.98%. This is comparable to the rest of the industry: ELES outperforms 45.28% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ELES is significantly below the industry average of 15.36%.
The 3 year average ROIC (4.69%) for ELES is below the current ROIC(6.98%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROIC 6.98%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ELES.MI Yearly ROA, ROE, ROICELES.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 3.48%, ELES is not doing good in the industry: 81.13% of the companies in the same industry are doing better.
In the last couple of years the Profit Margin of ELES has declined.
ELES has a Operating Margin of 12.08%. This is in the lower half of the industry: ELES underperforms 67.92% of its industry peers.
In the last couple of years the Operating Margin of ELES has grown nicely.
With a decent Gross Margin value of 51.40%, ELES is doing good in the industry, outperforming 73.58% of the companies in the same industry.
In the last couple of years the Gross Margin of ELES has grown nicely.
Industry RankSector Rank
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
ELES.MI Yearly Profit, Operating, Gross MarginsELES.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

ELES has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, ELES has more shares outstanding
Compared to 5 years ago, ELES has more shares outstanding
ELES has a better debt/assets ratio than last year.
ELES.MI Yearly Shares OutstandingELES.MI Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
ELES.MI Yearly Total Debt VS Total AssetsELES.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

2.2 Solvency

An Altman-Z score of 2.18 indicates that ELES is not a great score, but indicates only limited risk for bankruptcy at the moment.
ELES has a worse Altman-Z score (2.18) than 77.36% of its industry peers.
ELES has a debt to FCF ratio of 2.75. This is a good value and a sign of high solvency as ELES would need 2.75 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 2.75, ELES is doing good in the industry, outperforming 62.26% of the companies in the same industry.
A Debt/Equity ratio of 0.34 indicates that ELES is not too dependend on debt financing.
ELES's Debt to Equity ratio of 0.34 is on the low side compared to the rest of the industry. ELES is outperformed by 60.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Altman-Z 2.18
ROIC/WACC0.7
WACC10%
ELES.MI Yearly LT Debt VS Equity VS FCFELES.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M 20M 25M

2.3 Liquidity

A Current Ratio of 2.33 indicates that ELES has no problem at all paying its short term obligations.
ELES has a Current ratio (2.33) which is comparable to the rest of the industry.
ELES has a Quick Ratio of 1.79. This is a normal value and indicates that ELES is financially healthy and should not expect problems in meeting its short term obligations.
ELES has a Quick ratio (1.79) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.33
Quick Ratio 1.79
ELES.MI Yearly Current Assets VS Current LiabilitesELES.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 64.37% over the past year.
Measured over the past 5 years, ELES shows a small growth in Earnings Per Share. The EPS has been growing by 0.68% on average per year.
The Revenue has grown by 8.92% in the past year. This is quite good.
ELES shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.31% yearly.
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%

3.2 Future

The Earnings Per Share is expected to grow by 41.50% on average over the next years. This is a very strong growth
Based on estimates for the next years, ELES will show a quite strong growth in Revenue. The Revenue will grow by 10.52% on average per year.
EPS Next Y66.67%
EPS Next 2Y52.75%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue Next Year14.17%
Revenue Next 2Y12.55%
Revenue Next 3Y10.52%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ELES.MI Yearly Revenue VS EstimatesELES.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
ELES.MI Yearly EPS VS EstimatesELES.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.05 0.1 0.15

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 20.00, the valuation of ELES can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of ELES is on the same level as its industry peers.
ELES is valuated rather cheaply when we compare the Price/Earnings ratio to 28.78, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 15.69, which indicates a correct valuation of ELES.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ELES is on the same level as its industry peers.
When comparing the Price/Forward Earnings ratio of ELES to the average of the S&P500 Index (21.32), we can say ELES is valued slightly cheaper.
Industry RankSector Rank
PE 20
Fwd PE 15.69
ELES.MI Price Earnings VS Forward Price EarningsELES.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ELES is valued cheaply inside the industry as 90.57% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, ELES is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.61
EV/EBITDA 4.29
ELES.MI Per share dataELES.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ELES's earnings are expected to grow with 41.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.3
PEG (5Y)29.28
EPS Next 2Y52.75%
EPS Next 3Y41.5%

0

5. Dividend

5.1 Amount

ELES does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ELES SEMICONDUCTOR EQUIPMENT

BIT:ELES (4/24/2025, 7:00:00 PM)

1.6

+0.07 (+4.23%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners7.46%
Inst Owner ChangeN/A
Ins Owners31.74%
Ins Owner ChangeN/A
Market Cap27.26M
Analysts82.86
Price Target3.18 (98.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 20
Fwd PE 15.69
P/S 0.76
P/FCF 4.61
P/OCF 4.33
P/B 0.98
P/tB 1.51
EV/EBITDA 4.29
EPS(TTM)0.08
EY5%
EPS(NY)0.1
Fwd EY6.38%
FCF(TTM)0.35
FCFY21.67%
OCF(TTM)0.37
OCFY23.09%
SpS2.1
BVpS1.63
TBVpS1.06
PEG (NY)0.3
PEG (5Y)29.28
Profitability
Industry RankSector Rank
ROA 2.24%
ROE 4.47%
ROCE 10.95%
ROIC 6.98%
ROICexc 9.24%
ROICexgc 13.76%
OM 12.08%
PM (TTM) 3.48%
GM 51.4%
FCFM 16.55%
ROA(3y)1.61%
ROA(5y)2.47%
ROE(3y)3.53%
ROE(5y)5.33%
ROIC(3y)4.69%
ROIC(5y)4.15%
ROICexc(3y)6.24%
ROICexc(5y)5.97%
ROICexgc(3y)9.41%
ROICexgc(5y)8.84%
ROCE(3y)7.35%
ROCE(5y)6.52%
ROICexcg growth 3Y38.04%
ROICexcg growth 5Y10.61%
ROICexc growth 3Y34.42%
ROICexc growth 5Y9.58%
OM growth 3Y29.01%
OM growth 5Y12.15%
PM growth 3Y-8.14%
PM growth 5Y-6.16%
GM growth 3Y11.8%
GM growth 5Y5.73%
F-Score9
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 2.75
Debt/EBITDA 1.27
Cap/Depr 12.67%
Cap/Sales 1.08%
Interest Coverage 250
Cash Conversion 85.52%
Profit Quality 475.3%
Current Ratio 2.33
Quick Ratio 1.79
Altman-Z 2.18
F-Score9
WACC10%
ROIC/WACC0.7
Cap/Depr(3y)32.99%
Cap/Depr(5y)27.08%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)64.37%
EPS 3Y4.55%
EPS 5Y0.68%
EPS Q2Q%92.44%
EPS Next Y66.67%
EPS Next 2Y52.75%
EPS Next 3Y41.5%
EPS Next 5YN/A
Revenue 1Y (TTM)8.92%
Revenue growth 3Y23.37%
Revenue growth 5Y15.31%
Sales Q2Q%12.03%
Revenue Next Year14.17%
Revenue Next 2Y12.55%
Revenue Next 3Y10.52%
Revenue Next 5YN/A
EBIT growth 1Y38.54%
EBIT growth 3Y59.16%
EBIT growth 5Y29.31%
EBIT Next Year200%
EBIT Next 3Y58.14%
EBIT Next 5YN/A
FCF growth 1Y269.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y117.26%
OCF growth 3YN/A
OCF growth 5YN/A